Dr. Anil Kumar Anand

Dr. Anil Kumar Anand is the Principal Director and Head of Department of Radiation Oncology at Fortis Memorial Research Institute in Gurgaon, bringing over 33 years of distinguished clinical experience in precision cancer care. He completed his MBBS from Dayanand Medical College, Ludhiana, and earned his MD in Radiotherapy and Oncology from the prestigious Post Graduate Institute of Medical Education and Research (PGI), Chandigarh. His expertise is further enriched by specialised training in radiation therapy at New York Hospital Medical Centre of Queens, USA, and dedicated training in head and neck cancer radiotherapy at The Middlesex Hospital Medical School, London, UK.

Dr. Anand has developed particular mastery in advanced radiation techniques including Stereotactic Body Radiation Therapy (SBRT), Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy, Image-Guided Radiation Therapy, and CyberKnife Radiosurgery. His clinical work spans the full breadth of oncology—from external beam radiotherapy to intracavitary and interstitial brachytherapy, as well as intraoperative radiation therapy. He has published extensively on SBRT outcomes in recurrent head and neck cancers and maintains an active role in advancing radiation oncology standards through scientific contributions and professional leadership.

International patients form a significant part of Dr. Anand's practice at Fortis Gurgaon. He welcomes patients from across the Gulf region, North Africa, and South Asia, providing multilingual support in English and Hindi. His approach combines evidence-based protocols with personalised treatment planning, ensuring that each patient receives care tailored to their cancer stage, histology, and functional status. Many international patients value his approachability and clear communication of complex treatment options.

Fortis Memorial Research Institute is a Joint Commission International (JCI)-accredited facility renowned for its oncology excellence, advanced imaging infrastructure (CT simulators, MRI, PET-CT), and state-of-the-art radiotherapy equipment including linear accelerators and brachytherapy units. Located in Gurgaon, a major hub for medical tourism, the hospital offers a seamless experience for international visitors with dedicated international patient services, visa support, and comfortable accommodation options. Dr. Anand leads a team that emphasises meticulous quality assurance and outcomes tracking, ensuring benchmark standards of safety and efficacy.

International patients should know that Fortis Gurgaon is well-positioned for complex cancer cases requiring multidisciplinary care, with strong surgical and systemic oncology teams working alongside radiation oncology. Many patients from the Gulf and Africa choose to combine their radiotherapy course with tourism, making Gurgaon an accessible destination for comprehensive cancer treatment. Dr. Anand's long tenure and reputation within both Indian and international oncology circles make him a sought-after opinion for second opinions and complex case management.